S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
The Market Crash Shield is A.I. (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The Market Crash Shield is A.I. (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
The Market Crash Shield is A.I. (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The Market Crash Shield is A.I. (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
The Market Crash Shield is A.I. (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The Market Crash Shield is A.I. (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Intensity and insults rise as lawmakers debate debt ceiling
The Market Crash Shield is A.I. (Ad)pixel
Credit Suisse takeover hits heart of Swiss banking, identity
Small areas reopen near Fukushima nuclear plant, few return
The Market Crash Shield is A.I. (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:TRIB

Trinity Biotech - TRIB Stock Forecast, Price & News

$0.94
+0.02 (+2.17%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.89
▼
$0.94
50-Day Range
$0.87
▼
$1.18
52-Week Range
$0.84
▼
$1.55
Volume
19,710 shs
Average Volume
30,368 shs
Market Capitalization
$35.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Trinity Biotech MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.10% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.19) to $0.19 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.23 out of 5 stars

Medical Sector

973rd out of 1,004 stocks

Diagnostic Substances Industry

13th out of 14 stocks

See Top Rated MarketRank™ Stocks Here

TRIB stock logo

About Trinity Biotech (NASDAQ:TRIB) Stock

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Stock News Headlines

March 31, 2023 | americanbankingnews.com
Trinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.com
March 25, 2023 | finance.yahoo.com
What Is Trinity Biotech plc's (NASDAQ:TRIB) Share Price Doing?
April 1, 2023 | Legacy Research (Affiliate) (Ad)
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
March 23, 2023 | finance.yahoo.com
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results
March 22, 2023 | marketwatch.com
Trinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing Algorithm
March 22, 2023 | finance.yahoo.com
Trinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing Algorithm
March 22, 2023 | americanbankingnews.com
Trinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.com
March 22, 2023 | americanbankingnews.com
Trinity Biotech (TRIB) Scheduled to Post Quarterly Earnings on Thursday
April 1, 2023 | Vantage Point (Ad)
What’s At Stake In April is Shocking
The Fed will be meeting on a topic that could change trading forever, and the decision could come as soon as the end of April. But by taking the smartest approach now, you can help shield your assets and work toward your trading goals. Time, as always, is of the essence. Click on this link to see what you need to do right away. pixel
March 21, 2023 | techcrunch.com
This VC built a lab to make building biotech startups easier
March 16, 2023 | finance.yahoo.com
Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2022 Financial Results
February 23, 2023 | msn.com
Trinity International to scrap in-person undergraduate programs in favor of online classes
February 22, 2023 | finance.yahoo.com
Trinity Biotech Announces Entry Into An Increased Loan Facility to Fund Potential Acquisitions
February 9, 2023 | businessinsider.com
A biotech millionaire claimed his wild routine cut his biological age by 5 years. Scientists aren't sure most of it really works.
January 9, 2023 | wsj.com
Trinity Biotech Announces Strategic Partnership with imaware(TM) to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
January 9, 2023 | finance.yahoo.com
Trinity Biotech Announces Strategic Partnership with imaware™ to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
December 23, 2022 | msn.com
European Equities Rise Modestly in Friday Trading, End Week Up 1%
December 22, 2022 | finance.yahoo.com
Trinity Biotech plc (NASDAQ:TRIB) Q2 2022 Earnings Call Transcript
December 22, 2022 | finance.yahoo.com
Trinity Biotech plc (NASDAQ:TRIB) Q3 2022 Earnings Call Transcript
December 16, 2022 | markets.businessinsider.com
Here's what Wall Street expects from Trinity Biotech's earnings
December 15, 2022 | seekingalpha.com
Trinity Biotech plc (TRIB) Q3 2022 Earnings Call Transcript
December 15, 2022 | finance.yahoo.com
Trinity Biotech Announces Q3 2022 Financial Results
December 14, 2022 | msn.com
Trinity Biotech's Earnings: A Preview
December 9, 2022 | finance.yahoo.com
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
December 9, 2022 | finance.yahoo.com
Trinity Biotech plc to Announce Third Quarter Fiscal Year 2022 Financial Results
December 8, 2022 | msn.com
Pharma, Tech Sectors Help Buoy American Depositary Receipts of European Stocks
December 7, 2022 | msn.com
Pharama Stocks Nudge European Equities Modestly Higher in Wednesday Trading
See More Headlines
Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Company Calendar

Last Earnings
5/24/2021
Today
4/01/2023
Next Earnings (Estimated)
6/29/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRIB
CUSIP
N/A
CIK
888721
Web
www.trinitybiotech.com
Phone
(531) 276-9800
Fax
353-1276-9888
Employees
543
Year Founded
1992

Profitability

EPS (Most Recent Fiscal Year)
($1.29)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-41,010,000.00
Net Margins
-54.84%
Pretax Margin
-55.09%
Return on Equity
-724.07%
Return on Assets
-25.12%

Debt

Debt-to-Equity Ratio
8.70
Current Ratio
2.69
Quick Ratio
1.78

Sales & Book Value

Annual Sales
$74.78 million
Price / Sales
0.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.02) per share
Price / Book
-47.00

Miscellaneous

Outstanding Shares
38,108,000
Free Float
34,983,000
Market Cap
$35.82 million
Optionable
Optionable
Beta
1.43

Social Links


Key Executives

  • Aris Kekedjian
    Chairman & Chief Executive Officer
  • John Gillard
    CFO, Secretary & Executive Director
  • Eibhlin Kelly
    Chief Information Officer
  • Terence Dunne
    Director-Business Development
  • Fernando Devia
    Executive Vice President-Sales

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions













TRIB Stock - Frequently Asked Questions

How have TRIB shares performed in 2023?

Trinity Biotech's stock was trading at $0.99 at the beginning of the year. Since then, TRIB shares have decreased by 5.1% and is now trading at $0.94.
View the best growth stocks for 2023 here.

When is Trinity Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our TRIB earnings forecast.

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) announced its earnings results on Monday, May, 24th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.03. The business earned $25.59 million during the quarter. Trinity Biotech had a negative trailing twelve-month return on equity of 724.07% and a negative net margin of 54.84%.

Is Trinity Biotech a good dividend stock?

Trinity Biotech (NASDAQ:TRIB) pays an annual dividend of $0.22 per share and currently has a dividend yield of 0.00%.
Read our dividend analysis for TRIB.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

What is Trinity Biotech's stock symbol?

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trinity Biotech's stock price today?

One share of TRIB stock can currently be purchased for approximately $0.94.

How much money does Trinity Biotech make?

Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $35.82 million and generates $74.78 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis.

How many employees does Trinity Biotech have?

The company employs 543 workers across the globe.

How can I contact Trinity Biotech?

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888.

This page (NASDAQ:TRIB) was last updated on 4/1/2023 by MarketBeat.com Staff